Prevention, Diagnosis, and Treatment of Cervical Cancer

Harry J. Long, Nadia N.I. Laack, Bobbie S. Gostout

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


This article reviews the current data on human papillomavirus as the cause of most cervical cancer cases, data on the recently approved human papillomavirus vaccines, and updated information concerning the Bethesda System for interpretation of Papanicolaou test results. Current recommendations for surgical treatment, concurrent chemotherapy, and radiation therapy and recent advances in systemic therapy for advanced or metastatic cervical cancer are reviewed.

Original languageEnglish (US)
Pages (from-to)1566-1574
Number of pages9
JournalMayo Clinic proceedings
Issue number12
StatePublished - Dec 2007


  • CIN
  • FIGO
  • Fédération Internationale de Gynécologie et d'Obstétrique
  • GOG
  • Gynecologic Oncology Group
  • HDR
  • HPV
  • HR
  • LDR
  • Pap
  • Papanicolaou
  • cervical intraepithelial neoplasia
  • hazard ratio
  • high-dose rate
  • human papillomavirus
  • low-dose rate

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Prevention, Diagnosis, and Treatment of Cervical Cancer'. Together they form a unique fingerprint.

Cite this